Product NDC: | 0409-4903 |
Proprietary Name: | Lidocaine Hydrochloride |
Non Proprietary Name: | LIDOCAINE HYDROCHLORIDE |
Active Ingredient(s): | 20 mg/mL & nbsp; LIDOCAINE HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-4903 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA083158 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101129 |
Package NDC: | 0409-4903-34 |
Package Description: | 10 CARTON in 1 CONTAINER (0409-4903-34) > 1 SYRINGE in 1 CARTON > 5 mL in 1 SYRINGE |
NDC Code | 0409-4903-34 |
Proprietary Name | Lidocaine Hydrochloride |
Package Description | 10 CARTON in 1 CONTAINER (0409-4903-34) > 1 SYRINGE in 1 CARTON > 5 mL in 1 SYRINGE |
Product NDC | 0409-4903 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LIDOCAINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101129 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | LIDOCAINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE] |